first in human study - Robuta Search

https://adisinsight.springer.com/trials/700366692?error=cookies_not_supported&code=5b4c8ba0-cd37-4d66-b6dc-9573c311cde7 A Phase 1, First-in-Human Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of... The study will be conducted in 4 parts and will commence with dose escalation of AMX-500 as a monotherapy (Part 1), followed by monotherapy dose expansion (Part first in human study https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/a-multicenter-openlabel-firstinhuman-study A Multicenter, Open-label, First-in-Human Study of TYRA-200 in Advanced Intrahepatic... A Multicenter, Open-label, First-in-Human Study of TYRA-200 in Advanced Intrahepatic Cholangiocarcinoma and Other Solid Tumors with Activating FGFR2 Gene... first in human study https://adisinsight.springer.com/trials/700223676?error=cookies_not_supported&code=57740ecb-ae5f-4b1c-a591-e6c1618e0e1c Randomized, Double Blind, Placebo Controlled "First In-human" Study To Assess the Safety and... This phase Ia study investigated the tolerability of single ascending doses of PBF 509 [Palobiofarma] in volunteers. first in human study https://www.businesswire.com/news/home/20231214293384/en/Imperative-Care-Announces-First-In-Human-Study-of-Novel-Implant-Designed-to-Enable-Single-Antiplatelet-Therapy-After-Aneurysm-Treatment Imperative Care Announces First-In-Human Study of Novel Implant Designed to Enable Single... Imperative Care announces first-in-human clinical study for novel stent system designed to only require single antiplatelet therapy. first in human study https://www.globenewswire.com/fr/news-release/2025/01/08/3006197/0/en/AerWave-Completes-First-in-Human-Study-to-Advance-Disease-Modifying-Ultrasound-Based-Therapy-for-COPD-and-Asthma.html AerWave Completes First-in-Human Study to Advance AerWave Completes First-in-Human Study to Advance Disease-Modifying Ultrasound-Based Therapy for COPD and Asthma... first in human study completes advance https://events.diabetes.org/p/s/first-in-human-study-demonstrates-gip-receptor-gipr-antagonist-at7687-as-well-tolerated-and-suitable-for-once-weekly-subcutaneous-injection-for-treatment-in-people-living-with-obesity-5399 First-in-Human Study Demonstrates GIP Receptor (GIPR) Antagonist AT7687 as Well-Tolerated and... first in human study https://pubmed.ncbi.nlm.nih.gov/28095146/ Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin... Purpose B-cell leukemia/lymphoma-2 (BCL-2) overexpression is common in many non-Hodgkin lymphoma (NHL) subtypes. A phase I trial in patients with NHL was... first in human study https://adisinsight.springer.com/trials/700348138?error=cookies_not_supported&code=426a94dc-ff75-4f50-b27d-f2e338babe6f An Open-Label, First-In-Human Study Evaluating the Safety and Tolerability of VCTX210A Combination... This is an open-label, multicenter, Phase 1 study evaluating the safety and tolerability of VCTX210A combination product in patients with T1D first in human study https://adisinsight.springer.com/trials/700306423?error=cookies_not_supported&code=acce5059-5805-4e32-bb75-d2f2aeb16091 A first in human study evaluating a transdermal patch in healthy volunteers - AdisInsight This first in human study evaluated the safety and tolerability of a transdermal patch in healthy volunteers. first in human study transdermal patch healthy volunteers https://www.sciencedaily.com/releases/2010/09/100921084549.htm First in-human study of robotically assisted percutaneous coronary intervention system demonstrates... The first in-human study of a robotically assisted percutaneous coronary intervention system demonstrated that the technique was safe and feasible. first in human study https://adisinsight.springer.com/trials/700391320?error=cookies_not_supported&code=d7c4ec3c-ed76-462b-a1ae-eb81b637969a A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult... To evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis first in human study